05.2
[]. B M Ross, et al. Characterization of lysophospholipid metabolizing enzymes in human brain. J Neurochem. 994 Nov;63(5):839-48.
[2]. Gerd Schmitz, et al. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis. 200 Jan;208():0-8.
[3]. Lynda M Foulds, et al. Molecular identification of lyso-glycerophosphocholines as endogenous immunosuppressives in bovine and rat gonadal fluids. Biol Reprod. 2008 Sep;9(3):525-36.
[4]. Monika Riederer, et al. Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells. Atherosclerosis. 20 Feb;(2):338-44.
[5]. Sang-Yong Lee, et al. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors. Biochem Pharmacol. 205 Jan 5;93(2):-8.
H302-H35-H39-H33-H336-H35-H36-H32-H42
P260-P26-P264-P20-P2-P23-P280-P302+P352-P304+P340-P330-P362+P364-P405-P50
6.
28